$UNSS/Entrex Monster Merger.. Let's look at UNSS Share

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
471
$UNSS/Entrex Monster Merger..

Let's look at UNSS Share Details:
Par Value: $0.01 (per 10/22 8K; trading for 1/2 par value)
OS as of 4/14: 600m
OS as of 11/1: 600m (unchanged)
Insiders own 46% of the common shares
There are no Preferred shares, merger taking place in commons (Huge)

Assets (A/R): $23 million
Liabilities: $19,000 (one loan for $25,000 only drawn on once since 2016)
NO TOXIC CONVERTIBLES
Traded at $0.18 6 months ago, almost same share structure

A little more on Entrex:


- Merger is Defintive Agreement (done), not a LOI
-Watkins PR just added to the BOD of UNSS:


http://entrex.net/Entrex%20downloads/11-2019%...0Board.pdf

2 sites list revenues from $26-$32 million:

https://www.owler.com/company/entrex

https://www.zoominfo.com/c/entrex-inc/23874192


Company Management Team (look at their backgrounds):

http://entrex.net/leadership.html


Valuing the new entity:

Quote:
Entrex shareholders will receive 20% of the joint ventures revenues up to $31,000,000 distributed on a monthly basis and will own 40% of the equity of the entity. Universal will invest $4,000,000 in cash for 40% of the joint venture founding equity. Stephen H. Watkins, CEO of Entrex, is expected to join the UNSS Board of Directors. Universal also has a minimum buy-out option which allows it to purchase all remaining equity holders shares based on a minimum of 11.6 times a minimum trailing twelve-month EBITDA of $15,000,000 - resulting in a minimum enterprise value of $174,000,000. This valuation is expected to be 15% below market comparables providing Universal an estimated $30,000,000 in additional market valuation when and if the option is exercised.

The planned enterprise value is to be $174m, which is even a better gauge than just straight up market cap because it includes in its calculation the market capitalization of the company but also short-term and long-term debt as well as any cash on the company's balance sheet.

All estimates I am coming up with would/should value this at ~$0.05 minimum for starters. When you calculate Entrex shareholders are getting 80-90% new commons (again no preferreds, they are getting commons) that would value this at $0.0055 at about $6 million. Also how many times do you see a merger where the original shareholders are getting ~50% of the incoming company, usually it's 5-10%. Positive as well as commons are 46% held by insiders and the new shares will most likely be restricted for a while.

One time sales at the new SS would place this at $0.03, add in the new companies enterprise value of stated $174 million places this anywhere from $0.05-$0.15 for starters. Adding here as more $ is freed up. Ticker is still unknown on Ihub as there are only 40 some followers. That will change soon imo

Universal Solar Tech (UNSS) Stock Research Links

UNSS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading